Study types
- article 4
Condition tags
- endometriosis 3
- chronic_pelvic_pain 2
- adenomyosis 1
Top journals
Frequent coauthors
- Yamasaki Y 4
- Kaoruko Yamanaka 4
- Nagamata S 3
- Suganuma I 3
- Izumi Suganuma 3
- Jo Kitawaki 3
- Kitawaki J 3
- Kusuki I 3
- Izumi Kusuki 3
- Terai Y 3
Background/aimOvarian cancer is asymptomatic in its early stages, and often diagnosed at advanced stages, leading to a high recurrence rate. In recent years, exosomes have been shown to be useful for early-detection, prognosis prediction, a…
Introduction and importanceA case of Low-grade endometrial stromal sarcoma (LG-ESS) invading the great vessels is rare.Case presentationA 34-year-old female who had no past history presented to a previous hospital with abdominal distension.…
OBJECTIVE: This study elucidated the efficacy of Relugolix (REL) on the reduction of uterine volume and clinical symptoms for the treatment of adenomyosis. METHODS: We conducted a retrospective cohort study of patients who received REL (40…
BackgroundSerous endometrial intraepithelial carcinoma (SEIC) is now considered to represent an early stage of uterine serous carcinoma (USC). It is an intraepithelial lesion but has been reported to cause extrauterine metastases. We report…
ObjectivesLow-dose estrogen-progestin (LEP) agents are often used for relieving endometriosis-associated chronic pelvic pain, but a direct effect of LEP on endometriotic lesions remains to be demonstrated. The objective of this study is to …
ObjectiveTo determine the effect of dienogest (DNG) on the expression of aromatase and cyclooxygenase-2 (COX-2) and the production of prostaglandin E(2) (PGE(2)) in human endometriotic stromal cells (ESCs).DesignExperimental study in vitro.…
ObjectiveTo examine whether long-term administration of dienogest following gonadotropin-releasing hormone agonist (GnRH-a) therapy would prolong the relief of pelvic pain while reducing the amount of irregular uterine bleeding.Study design…